Formfactor Inc: Form 10-Q for the period ended Sep 28, 2019
Filed with the SEC on Nov 5, 2019 and accepted by EDGAR at Nov 5, 2019, 15:44 ET.
Management's discussion and analysis
As filed, 29,785 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Cautionary Statement Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, which are subject to risks and uncertainties. The forward-looking statements include statements concerning, among other things, our business strategy, financial and operating results, gross margins, liquidity and capital expenditure requirements, impact of accounting standards and our share repurchase plan. In some cases, you can identify these statements by forward-looking words, such as "may," "might," "will," "could," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "intend" and "continue," the negative or plural of these words and other comparable terminology.
The forward-looking statements are only predictions based on our current expectations and our projections about future events. All forward-looking statements included in this Quarterly Report on Form 10-Q are based upon information available to us as of the filing date of this Quarterly Report on Form 10-Q. You should not place undue reliance on these forward-looking statements. We have no obligation to update any of these statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements, including risks related to general market trends, our ability to execute our business strategy and other risks discussed in the section titled “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 29, 2018 and in this Quarterly Report on Form 10-Q. You should carefully consider the numerous risks and uncertainties described under these sections.
The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and the accompanying notes contained in this Quarterly Report on Form 10-Q. Unless expressly stated or the context otherwise requires, the terms “we,” “our,” “us” and “FormFactor” refer to FormFactor, Inc. and its subsidiaries.
Overview
FormFactor, Inc., headquartered in Livermore, California, is a leading provider of test and measurement technologies. We provide a broad range of high-performance probe cards, analytical probes, probe stations and thermal sub-systems to both semiconductor companies and scientific institutions. Our products provide information from a variety of semiconductor and electro-optical devices and integrated circuits from research, to development through production. Customers use our products and services to lower production costs, improve yields, and enable development of their complex next-generation products.
We operate in two reportable segments consisting of the Probe Cards segment and the Systems segment. Sales of our probe cards and analytical probes are included in the Probe Cards segment, while sales of our probe stations and thermal sub-systems are included in the Systems segment.
We generated net income of $20.7 million in the first nine months of fiscal 2019 as compared to $18.9 million in the first nine months of fiscal 2018. The increase in net income was primarily due to higher revenues, partially offset by higher operating expenses and a higher effective income tax rate.
Critical Accounting Policies and the Use of Estimates
Management’s Discussion and Analysis and Note 2 to the Consolidated Financial Statements in our 2018 Annual Report on Form 10-K describe the significant accounting estimates and critical accounting policies used in preparation of the Consolidated Financial Statements. Actual results in these areas could differ from management’s estimates. During the nine months ended September 28, 2019, there were no significant changes in our critical accounting policies or estimates from those reported in our Annual Report on Form 10-K for the year ended December 29, 2018, which was filed with the Securities and Exchange Commission on February 26, 2019.
Results of Operations
The following table sets forth our operating results as a percentage of revenues for the periods indicated:
| Three Months Ended September 28, 2019 | September 29, 2018 | Nine Months Ended September 28, 2019 | September 29, 2018 | |
|---|---|---|---|---|
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of revenues | 60.7 | 60.8 | 60.3 | 60.3 |
| Gross profit | 39.3 | 39.2 | 39.7 | 39.7 |
| Operating expenses: | ||||
| Research and development | 14.3 | 14.0 | 14.6 | 14.6 |
| Selling, general and administrative | 18.4 | 18.3 | 18.8 | 18.9 |
| Total operating expenses | 32.7 | 32.3 | 33.4 | 33.5 |
| Operating income | 6.6 | 6.9 | 6.3 | 6.2 |
| Interest income | 0.5 | 0.3 | 0.5 | 0.2 |
| Interest expense | (0.3) | (0.6) | (0.4) | (0.7) |
| Other income (expense), net | 0.2 | 0.1 | 0.1 | (0.2) |
| Income before income taxes | 7.0 | 6.7 | 6.5 | 5.5 |
| Provision for income taxes | 1.1 | 1.0 | 1.5 | 0.9 |
| Net income | 5.9% | 5.7% | 5.0% | 4.6% |
Revenues by Segment and Market
(In thousands)
| Three Months Ended September 28, 2019 | September 29, 2018 | Nine Months Ended September 28, 2019 | September 29, 2018 | |
|---|---|---|---|---|
| Probe Cards | $116,447 | $111,606 | $338,187 | $318,120 |
| Systems | 24,157 | 23,383 | 72,648 | 70,668 |
| $140,604 | $134,989 | $410,835 | $388,788 |
22
(Dollars in thousands)
| Probe Cards Markets: | Three Months Ended September 28, 2019 | % of Revenues | September 29, 2018 | % of Revenues | $ Change | % Change |
|---|---|---|---|---|---|---|
| Foundry & Logic | $68,431 | 48.7% | $61,270 | 45.4% | $7,161 | 11.7% |
| DRAM | 39,425 | 28.0 | 37,359 | 27.7 | 2,066 | 5.5 |
| Flash | 8,591 | 6.1 | 12,977 | 9.6 | (4,386) | (33.8) |
| Systems Market: | ||||||
| Systems | 24,157 | 17.2 | 23,383 | 17.3 | 774 | 3.3 |
| Total revenues | $140,604 | 100.0% | $134,989 | 100.0% | $5,615 | 4.2% |
| Nine Months Ended | ||||||
| September 28, 2019 | % of Revenues | September 29, 2018 | % of Revenues | $ Change | % Change | |
| (Dollars in thousands) | ||||||
| Probe Cards Markets: | ||||||
| Foundry & Logic | $213,453 | 51.9% | $181,819 | 46.7% | $31,634 | 17.4% |
| DRAM | 104,355 | 25.4 | 105,716 | 27.2 | (1,361) | (1.3) |
| Flash | 20,379 | 5.0 | 30,585 | 7.9 | (10,206) | (33.4) |
| Systems Market: | ||||||
| Systems | 72,648 | 17.7 | 70,668 | 18.2 | 1,980 | 2.8 |
| Total revenues | $410,835 | 100.0% | $388,788 | 100.0% | $22,047 | 5.7% |
The increases in Foundry & Logic product revenue for the three months ended September 28, 2019, compared to the three months ended September 29, 2018, was driven by market penetration with a large semiconductor foundry. The increase in Foundry & Logic product revenue for the nine months ended September 28, 2019, compared to the nine months ended September 29, 2018, was primarily the result of lower demand in the prior year from one major customer as a result of delays in its node transitions. This major customer accounted for 23.8% of total revenues for the nine months ended September 28, 2019, compared to 18.0% for the nine months ended September 29, 2018.
The decreases in Flash product revenue for the three and nine months ended September 28, 2019, compared to the three and nine months ended September 29, 2018, were driven by decreased unit sales as a result of decreased customer demand.
The increases in Systems product revenue for the three and nine months ended September 28, 2019, compared to the three and nine months ended September 29, 2018, were driven by increased sales of probe stations, which includes a new 200mm platform, partially offset by lower revenue from thermal sub-systems.
Revenues by Geographic Region
(Dollars in thousands)
| Three Months Ended September 28, 2019 | % of Revenue | September 29, 2018 | % of Revenue | Nine Months Ended September 28, 2019 | % of Revenue | September 29, 2018 | % of Revenue | |
|---|---|---|---|---|---|---|---|---|
| United States | $33,665 | 23.9% | $40,127 | 29.7% | $106,297 | 25.9% | $105,668 | 27.2% |
| South Korea | 23,597 | 16.8 | 20,874 | 15.5 | 78,491 | 19.1 | 61,905 | 15.9 |
| China | 31,383 | 22.3 | 22,080 | 16.4 | 73,581 | 17.9 | 48,993 | 12.6 |
| Taiwan | 18,255 | 13.0 | 19,809 | 14.7 | 55,514 | 13.5 | 77,759 | 20.0 |
| Japan | 16,929 | 12.0 | 14,735 | 10.9 | 43,454 | 10.6 | 41,905 | 10.8 |
| Europe | 9,548 | 6.8 | 9,128 | 6.8 | 29,689 | 7.2 | 30,180 | 7.8 |
| Asia-Pacific1 | 5,665 | 4.0 | 7,230 | 5.4 | 16,611 | 4.0 | 19,277 | 5.0 |
| Rest of the world | 1,562 | 1.2 | 1,006 | 0.6 | 7,198 | 1.8 | 3,101 | 0.7 |
| Total revenues | $140,604 | 100.0% | $134,989 | 100.0% | $410,835 | 100.0% | $388,788 | 100.0% |
1 Asia-Pacific includes all countries in the region except China, Japan, South Korea and Taiwan, which are disclosed separately.
Geographic revenue information is based on the location to which we ship the product. For example, if a certain South Korean customer purchases through their U.S. subsidiary and requests the products to be shipped to an address in South Korea, this sale will be reflected in the revenue for South Korea rather than the U.S.
Changes in revenue by geographic region for the three and nine months ended September 28, 2019, compared to the three and nine months ended September 29, 2018, were primarily attributable to changes in customer demand, shifts in customer regional manufacturing strategies, and product sales mix. The most significant change in revenue by geographic region for the three and nine months ended September 28, 2019, compared to the three and nine months ended September 29, 2018 was within China, which was attributable to shifts in customer regional manufacturing strategies with large multinationals.
Cost of Revenues and Gross Margins
Cost of revenues consists primarily of manufacturing materials, compensation and benefits, shipping and handling costs, manufacturing-related overhead and amortization of certain intangible assets. Our manufacturing operations rely on a limited number of suppliers to provide key components and materials for our products, some of which are a sole source. We order materials and supplies based on backlog and forecasted customer orders. Tooling and setup costs related to changing manufacturing lots at our suppliers are also included in the cost of revenues. We expense all warranty costs, inventory provisions and amortization of certain intangible assets as cost of revenues.
Our gross profit and gross margin were as follows (dollars in thousands):
| Three Months Ended September 28, 2019 | September 29, 2018 | $ Change | % Change | |
|---|---|---|---|---|
| Gross profit | $55,318 | $52,970 | $2,348 | 4.4% |
| Gross margin | 39.3% | 39.2% | ||
| Nine Months Ended | ||||
| September 28, 2019 | September 29, 2018 | $ Change | % Change | |
| Gross profit | $163,191 | $154,317 | $8,874 | 5.8% |
| Gross margin | 39.7% | 39.7% |
24
Our gross profit and gross margin by segment were as follows (dollars in thousands):
| Three Months Ended September 28, 2019 Probe Cards Systems Corporate and Other Total | September 29, 2018 Probe Cards Systems Corporate and Other Total | |
|---|---|---|
| Gross profit | $48,127 $13,015 $(5,824) $55,318 | $47,675 $11,250 $(5,955) $52,970 |
| Gross margin | 41.3% 53.9% —% 39.3% | 42.7% 48.1% —% 39.2% |
| Nine Months Ended | ||
| September 28, 2019 | September 29, 2018 | |
| Probe Cards Systems Corporate and Other Total | Probe Cards Systems Corporate and Other Total | |
| Gross profit | $141,913 $38,703 $(17,425) $163,191 | $138,182 $34,118 $(17,983) $154,317 |
| Gross margin | 42.0% 53.3% —% 39.7% | 43.4% 48.3% —% 39.7% |
Probe Cards
For the three and nine months ended September 28, 2019, gross profit increased compared to the three and nine months ended September 29, 2018, primarily due to increased sales and higher factory utilization, offset by less favorable product mix. Gross margins decreased due to less favorable product mix.
Systems
For the three and nine months ended September 28, 2019, gross profit and gross margin increased compared to the three and nine months ended September 29, 2018, due to increased sales and a favorable product mix.
Corporate and Other
Corporate and Other includes unallocated expenses relating to amortization of intangible assets, share-based compensation expense, and restructuring charges, net, which are not used in evaluating the results of, or in allocating resources to, our reportable segments.
Overall
Gross profit and gross margin fluctuate with revenue levels, product mix, selling prices, factory loading and material costs. For the three and nine months ended September 28, 2019, compared to the three and nine months ended September 29, 2018, gross profit increased due to increased sales while gross margins remained relatively consistent with fluctuations in product mix and factory utilizations.
Cost of revenues included stock-based compensation expense as follows (in thousands):
| Three Months Ended September 28, 2019 | September 29, 2018 | Nine Months Ended September 28, 2019 | September 29, 2018 | |
|---|---|---|---|---|
| Stock-based compensation | $1,117 | $832 | $3,031 | $2,565 |
Future gross margins may be adversely impacted by lower revenues, unfavorable product mix and lower factory utilization even though we have taken significant steps to reduce our operating cost structure. Our gross margins may also be adversely affected if we are required to record additional inventory write-downs for estimated average selling prices that are below cost or because of a decrease in demand.
Research and Development
(Dollars in thousands)
| Three Months Ended September 28, 2019 | September 29, 2018 | $ Change | % Change | |
|---|---|---|---|---|
| Research and development | $20,096 | $18,857 | $1,239 | 6.6% |
| % of revenues | 14.3% | 14.0% | ||
| Nine Months Ended | ||||
| September 28, 2019 | September 29, 2018 | $ Change | % Change | |
| (Dollars in thousands) | ||||
| Research and development | $59,893 | $56,578 | $3,315 | 5.9% |
| % of revenues | 14.6% | 14.6% |
The increases in research and development expenses in the three and nine months ended September 28, 2019 when compared to the corresponding periods in the prior year were primarily driven by annual compensation and benefit adjustments, partially offset by a decrease in project material costs.
A detail of the changes is as follows (in millions):
| Three Months Ended September 28, 2019 compared to Three Months Ended September 29, 2018 | Nine Months Ended September 28, 2019 compared to Nine Months Ended September 29, 2018 | |
|---|---|---|
| Employee compensation costs | $1.1 | $2.5 |
| Stock-based compensation | 0.4 | 1.0 |
| Project material costs | (0.6) | (1.1) |
| Depreciation | 0.1 | 0.4 |
| Other general operations | 0.2 | 0.5 |
| $1.2 | $3.3 |
Research and development included stock-based compensation expense as follows (in thousands):
| Three Months Ended September 28, 2019 | September 29, 2018 | Nine Months Ended September 28, 2019 | September 29, 2018 | |
|---|---|---|---|---|
| Stock-based compensation | $1,729 | $1,312 | $4,830 | $3,870 |
26
Selling, General and Administrative
(Dollars in thousands)
| Three Months Ended September 28, 2019 | September 29, 2018 | $ Change | % Change | |
|---|---|---|---|---|
| Selling, general and administrative | $25,887 | $24,745 | $1,142 | 4.6% |
| % of revenues | 18.4% | 18.3% | ||
| Nine Months Ended | ||||
| September 28, 2019 | September 29, 2018 | $ Change | % Change | |
| (Dollars in thousands) | ||||
| Selling, general and administrative | $77,354 | $73,426 | $3,928 | 5.3% |
| % of revenues | 18.8% | 18.9% |
The increases in selling, general and administrative in the three and nine months ended September 28, 2019 when compared to the corresponding periods in the prior year were primarily due to higher stock-based compensation related to the timing of annual grants, annual compensation and benefit adjustments, and headcount, offset partially by a decrease in the amortization of intangible assets. The increase for the nine months ended September 28, 2019 when compared to the corresponding period in the prior year was offset partially by a reduction in consulting fees.
A detail of the changes is as follows (in millions):
| Three Months Ended September 28, 2019 compared to Three Months Ended September 29, 2018 | Nine Months Ended September 28, 2019 compared to Nine Months Ended September 29, 2018 | |
|---|---|---|
| Stock-based compensation | $1.3 | $3.2 |
| Employee compensation | 0.7 | 1.7 |
| Consulting fees | — | (1.2) |
| Amortization of intangibles | (1.0) | (0.3) |
| General operating expenses | 0.1 | 0.5 |
| $1.1 | $3.9 |
Selling, general and administrative included stock-based compensation expense as follows (in thousands):
| Three Months Ended September 28, 2019 | September 29, 2018 | Nine Months Ended September 28, 2019 | September 29, 2018 | |
|---|---|---|---|---|
| Stock-based compensation | $3,658 | $2,393 | $9,227 | $5,986 |
27
Interest Income and Interest Expense
(Dollars in thousands)
| Three Months Ended September 28, 2019 | September 29, 2018 | Nine Months Ended September 28, 2019 | September 29, 2018 | |
|---|---|---|---|---|
| Interest Income | $724 | $369 | $1,988 | $952 |
| Weighted average balance of cash and investments | $193,092 | $134,516 | $173,975 | $136,986 |
| Weighted average yield on cash and investments | 2.02% | 1.50% | 2.07% | 1.46% |
| Interest Expense | $422 | $777 | $1,539 | $2,654 |
| Average debt outstanding | $46,250 | $84,725 | $56,113 | $96,003 |
| Weighted average interest rate on debt | 4.26% | 4.09% | 4.42% | 3.88% |
Interest income is earned on our cash, cash equivalents, restricted cash and marketable securities. The increases in interest income for the three and nine months ended September 28, 2019 compared with the corresponding periods of the prior year were attributable to higher investment yields, as well as higher average investment balances.
Interest expense primarily includes interest on our term loan and interest-rate swap derivative contracts, as well as term loan issuance costs amortization charges. The decreases in interest expense for the three and nine months ended September 28, 2019 compared to the same periods of the prior year were primarily due to lower outstanding debt balances as a result of principal payments made, partially offset by higher interest rates.
Other Income (Expense), Net
Other income (expense), net, primarily includes the effects of foreign currency impact and various other gains and losses.
Provision for Income Taxes
(In thousands, except percentages)
| Three Months Ended September 28, 2019 | September 29, 2018 | Nine Months Ended September 28, 2019 | September 29, 2018 | |
|---|---|---|---|---|
| Provision for income taxes | $1,584 | $1,393 | $5,906 | $3,334 |
| Effective tax rate | 16.1% | 15.3% | 22.2% | 15.0% |
Provision for income taxes reflects the tax provision on our operations in foreign and U.S. jurisdictions, offset by tax benefits from lapsing of statute of limitations related to uncertain tax positions in the U.S. and excess tax benefits from share based compensation plans. In the fourth quarter of fiscal 2018, we released our valuation allowance against certain U.S. deferred tax assets as sufficient positive evidence existed to support the realization of such deferred tax assets, resulting in an increase in our effective tax rate for the three and nine months ended September 28, 2019 compared to the three and nine months ended September 29, 2018.
Liquidity and Capital Resources
Capital Resources
Our working capital was $247.9 million at September 28, 2019, compared to $235.3 million at December 29, 2018.
Cash and cash equivalents primarily consist of deposits held at banks and money market funds. Marketable securities primarily consist of U.S. treasuries, U.S. agency securities and corporate bonds. We typically invest in highly-rated securities with low probabilities of default. Our investment policy requires investments to be rated single A or better, and limits the types of acceptable investments, issuer concentration and duration of the investment.
Our cash, cash equivalents and marketable securities totaled approximately $200.0 million at September 28, 2019, compared to $149.0 million at December 29, 2018. We believe that we will be able to satisfy our working capital requirements and scheduled term loan repayments for at least the next twelve months with the liquidity provided by our existing cash, cash equivalents, marketable securities and cash provided by operations. To the extent necessary, we may consider entering into short and long-
term debt obligations, raising cash through a stock issuance, or obtaining new financing facilities, which may not be available on terms favorable to us. Our future capital requirements may vary materially from those now planned.
After the third quarter ended September 28, 2019, we entered into a loan agreement for €21.0 million; see Note 15 of Notes to Condensed Consolidated Financial Statements for additional information.
If we are unsuccessful in maintaining or growing our revenues, maintaining or reducing our cost structure (in response to an industry demand downturn or other event), or increasing our available cash through debt or equity financings, our cash, cash equivalents and marketable securities may decline in fiscal 2019.
We utilize a variety of tax planning and financing strategies to manage our worldwide cash and deploy funds to locations where needed. As part of these strategies, we indefinitely reinvest a portion of our foreign earnings. Should we require additional capital in the United States, we may elect to repatriate indefinitely-reinvested foreign funds or raise capital in the United States.
Cash Flows
The following table sets forth our net cash flows from operating, investing and financing activities:
(In thousands)
| Nine Months Ended September 28, 2019 | September 29, 2018 | |
|---|---|---|
| Net cash provided by operating activities | $83,378 | $46,138 |
| Net cash used in investing activities | (40,047) | (13,463) |
| Net cash used in financing activities | (18,976) | (31,732) |
Operating Activities
Net cash provided by operating activities for the nine months ended September 28, 2019 was primarily attributable to net income of $20.7 million and $62.1 million of net non-cash expenses, offset by changes in operating assets and liabilities.
Accounts receivable, net, decreased $10.6 million to $84.8 million at September 28, 2019, compared to $95.3 million at December 29, 2018, as a result of changes in customer sales mix, timing of customer shipments and timing of customer payments.
Inventories, net, increased $8.3 million to $86.0 million at September 28, 2019, compared to $77.7 million at December 29, 2018, as a result of increased inventory purchases to shorten lead time and improve pricing, and timing of customer demand.
Accounts payable increased $11.0 million to $51.0 million at September 28, 2019, compared to $40.0 million at December 29, 2018, as a result of timing of vendor payments.
Investing Activities
Net cash used in investing activities for the nine months ended September 28, 2019 was primarily related to $25.9 million of net purchases of marketable securities, as well as $14.2 million of cash used in the acquisition of property, plant and equipment.
Financing Activities
Net cash used in financing activities for the nine months ended September 28, 2019 primarily related to $18.8 million of principal payments made towards the repayment of our term loan and $7.9 million related to tax withholdings associated with the net share settlements of our equity awards, partially offset by $7.7 million of proceeds received from issuances of common stock under our employee stock purchase plan and stock option plans.
Debt
2016 Facility
On June 24, 2016, we entered into a credit agreement (the “Credit Agreement”) with HSBC Bank USA, National Association ("HSBC"). Pursuant to the Credit Agreement, the lenders provided us with a senior secured term loan facility of $150 million (the “Term Loan”). The proceeds of the Term Loan were used to finance a portion of the purchase price paid in connection with the acquisition of Cascade Microtech.
The Term Loan bears interest at a rate equal to, at our option, (i) the applicable London Interbank Offered Rate ("LIBOR") rate plus 2.00% per annum or (ii) Base Rate (as defined in the Credit Agreement) plus 1.00% per annum. We have currently elected to pay interest at 2.00% over the one-month LIBOR rate. Interest payments are payable in monthly installments over a five-year period.
On July 25, 2016, we entered into an interest rate swap agreement with HSBC and other lenders to hedge the interest payments on the Term Loan for the notional amount of $95.6 million. As future levels of LIBOR over the life of the loan are uncertain, we entered into these interest-rate swap agreements to hedge the exposure in interest rate risks associated with movement in LIBOR rates. By entering into the agreements, we convert a floating rate interest at one-month LIBOR plus 2% into a fixed rate interest at 2.939%. As of September 28, 2019, the notional amount of the loan that is subject to this interest rate swap is $33.8 million. See Note 7 of Notes to Condensed Consolidated Financial Statements for additional information.
The Term Loan amortizes in equal quarterly installments, which began June 30, 2016, in annual amounts equal to 5% for year one, 10% for year two, 20% for year three, 30% for year four and 35% for year five. The Credit Agreement allows voluntary prepayment to be made at any time to prepay the Term Loan in whole or in part without penalty or premium. As of September 28, 2019, we have made prepayments of $40.0 million in addition to scheduled installments per the Credit Agreement. For the three and nine months ended September 28, 2019, we did not make any prepayments in addition to scheduled installments. We expect the scheduled installments per the Credit Agreement to pay the remaining debt in the next 12 months.
The obligations under the Term Loan are guaranteed by substantially all of our assets and the assets of our domestic subsidiaries, subject to certain customary exceptions.
The Credit Agreement contains negative covenants customary for financing of this type, as well as certain financial maintenance covenants. As of September 28, 2019, the balance outstanding pursuant to the Term Loan was $46.3 million at an interest rate of 4.1% and we were in compliance with all covenants under the Credit Agreement.
2019 Facility
On October 25, 2019, FormFactor GmbH and ATT Advanced Temperature Test Systems GmbH, our wholly owned subsidiaries, entered into a credit facility agreement (the "Credit Facility Agreement") with HSBC Trinkaus & Burkhardt AG. The Credit Facility Agreement provides for a three-year loan in the amount of €21.0 million (the "credit facility"). The credit facility bears interest at a rate equal to the Euro Interbank Offered Rate ("EURIBOR") plus 1.75% per annum. The credit facility will be repaid in quarterly installments of €1.75 million plus interest beginning January 25, 2020.
Stock Repurchase Program
In February 2017, our Board of Directors authorized a program to repurchase up to $25 million of outstanding common stock to offset potential dilution from issuances of common stock under our stock-based compensation plans. The share repurchase program will expire on February 1, 2020. During the nine months ended September 28, 2019, we did not repurchase any shares of common stock and, as of September 28, 2019, $6.0 million remained available for future repurchases.
Repurchased shares are retired upon the settlement of the related trade transactions with the excess of cost over par value charged to additional paid-in capital. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.
Contractual Obligations and Commitments
Other than our operating lease commitments as disclosed in Note 12 of Notes to Condensed Consolidated Financial Statements, our contractual obligations and commitments have not materially changed as of September 28, 2019 from those disclosed in our Annual Report on Form 10-K for the year ended December 29, 2018.
Off-Balance Sheet Arrangements
Historically, we have not participated in transactions that have generated relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of September 28, 2019, we were not involved in any such off-balance sheet arrangements.
Recent Accounting Pronouncements
See Note 1 of Notes to Condensed Consolidated Financial Statements.
Market risk
As filed, 370 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to Item 7A “Quantitative and Qualitative Disclosures about Market Risk” contained in Part II of our Annual Report on Form 10-K for the fiscal year ended December 29, 2018. Our exposure to market risk has not changed materially since December 29, 2018.
Controls and procedures
As filed, 3,051 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Based on our management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on the Effectiveness of Controls
Control systems, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any control systems must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of a simple error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
CEO and CFO Certifications
We have attached as exhibits to this Quarterly Report on Form 10-Q the certifications of our Chief Executive Officer and Chief Financial Officer, which are required in accordance with the Exchange Act. We recommend that this Item 4 be read in conjunction with the certifications for a more complete understanding of the subject matter presented.
Risk factors
As filed, 707 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes during the nine months ended September 28, 2019 to the risk factors discussed in our Annual Report on Form 10-K for the year ended December 29, 2018. If any of the identified risks actually occur, our business, financial condition and results of operations could suffer. The trading price of our common stock could decline and you may lose all or part of your investment in our common stock. The risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 29, 2018 are not the only ones we face. Additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business operations.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-09-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-06-30 to 2019-09-28 | $140.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2018-12-30 to 2019-09-28 | $410.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-06-30 to 2019-09-28 | $85.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2018-12-30 to 2019-09-28 | $247.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-06-30 to 2019-09-28 | $55.3m | us-gaap:GrossProfit |
| Gross profit | 9 months2018-12-30 to 2019-09-28 | $163.2m | us-gaap:GrossProfit |
| Research and development | 3 months2019-06-30 to 2019-09-28 | $20.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2018-12-30 to 2019-09-28 | $59.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-06-30 to 2019-09-28 | $25.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2018-12-30 to 2019-09-28 | $77.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-06-30 to 2019-09-28 | $9.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2018-12-30 to 2019-09-28 | $25.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-06-30 to 2019-09-28 | $422.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2018-12-30 to 2019-09-28 | $1.5m | us-gaap:InterestExpense |
| Income tax | 3 months2019-06-30 to 2019-09-28 | $1.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2018-12-30 to 2019-09-28 | $5.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-06-30 to 2019-09-28 | $8.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2018-12-30 to 2019-09-28 | $20.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-06-30 to 2019-09-28 | $0.11 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2018-12-30 to 2019-09-28 | $0.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-06-30 to 2019-09-28 | $0.11 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2018-12-30 to 2019-09-28 | $0.28 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-06-30 to 2019-09-28 | 77,291,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2018-12-30 to 2019-09-28 | 76,763,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2018-12-30 to 2019-09-28 | $83.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2018-12-30 to 2019-09-28 | $14.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2019-09-28 | $122.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-09-28 | $389.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-09-28 | $793.6m | us-gaap:Assets |
| Current liabilities | At period end2019-09-28 | $141.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-09-28 | $179.1m | us-gaap:Liabilities |
| Long-term debt | At period end2019-09-28 | $0 | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-09-28 | $46.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2019-09-28 | $614.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001039399-19-000083. Last ingested by Listed: Nov 13, 2026, 15:19 ET. Listed shows no prices and gives no investment advice.